Cite
MLA Citation
Ioannis Karydis et al.. “Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma.” Oncoimmunology, vol. 5, 2016, p. . http://access.bl.uk/ark:/81055/vdc_100033975757.0x000024
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ioannis Karydis et al.. “Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma.” Oncoimmunology, vol. 5, 2016, p. . http://access.bl.uk/ark:/81055/vdc_100033975757.0x000024